secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dare Bioscience, Inc. (DARE)
CIK:        0001401914
Form:       8-K
Filed at:   2024-01-26T23:59:59+00:00
Accession:  0001493152-24-003984
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dare Bioscience announces CFO retirement, CCO resignation, board downsizing
---------------------------------------------------------------------------

- CFO Lisa Walters-Hoffert retired effective Jan. 26, 2024; will consult for 9 months at $31,667/month.
- CCO John Fair resigns effective June 30, 2024; part-time from Apr. 1; no replacement planned.
- MarDee Haring-Layton appointed Chief Accounting Officer; CEO Johnson will serve as principal financial officer.
- Board to shrink from 8 to 6; directors Blanchard and Ononye-Onyia to resign before 2024 annual meeting.
- Non-employee director cash compensation reduced to 25th percentile of peer group.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401914/000149315224003984/0001493152-24-003984-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401914/000149315224003984/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-003984

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer